Neopterin for risk assessment in angina pectoris

Drug News and Perspectives

Volumn 22, Issue 4, 2009, Pages 215-219

  Avanzas, Pablo ^a   Kaski, Juan Carlos ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BIOPTERIN; GUANOSINE TRIPHOSPHATE; NEOPTERIN; PRAVASTATIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGINA PECTORIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; PATHOGENESIS; PROGNOSIS; REVIEW; RISK ASSESSMENT; STABLE ANGINA PECTORIS;

ANGINA PECTORIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; NEOPTERIN; RISK; RISK ASSESSMENT;

EID: 67651226899     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2009.22.4.1367710     Document Type: Review

References (58)

1. Ross, R. Atherosclerosis is an inflammatory disease. Am Heart J 1999, 138(5, Pt 2): S419-20.
2. Pearson, T.A., Mensah, G.A., Alexander, R.W. et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3): 499-511.
3. Zebrack, J.S., Muhlestein, J.B., Horne, B.D. and Anderson, J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002, 39(4): 632-637
4. Arroyo-Espliguero, R., Avanzas, P., Cosin-Sales, J., Aldama, C., Pizzi, C. and Kaski, J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004; 25(5):401-408. (Pubitemid 38391522)
5. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. and Hennekens, C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336(14): 973-979 (Pubitemid 27152782)
6. Kaski, J.C., Avanzas, P. and Arroyo-Espliguero, R. Neopterin-a forgotten biomarker. J Am Coll Cardiol 2003, 42(6): 1142-1143
7. Kaski, J.C., Avanzas, P. and Arroyo-Espliguero R. Neopterin: Still a forgotten biomarker. Clin Chem 2005, 51(10): 1902-1903
8. Avanzas, P., Arroyo-Espliguero, R., Cosin-Sales, J., Quiles, J., Zouridakis, E. and Kaski, J.C. Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Am J Cardiol 2004, 93(5): 627-629 (Pubitemid 38293075)
9. Avanzas, P., Arroyo-Espliguero, R., Quiles, J., Roy, D. and Kaski, J.C. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005, 26(5): 457-463 (Pubitemid 40314761)
10. Kaski, J.C., Consuegra-Sanchez, L., Fernandez-Berges, D.J. et al. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis 2008.
11. Ray, K.K., Morrow, D.A., Sabatine, M.S. et al. Long-term prognostic value of neopterin: A novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007, 115(24): 3071-3078
12. van Haelst, P.L., Liem, A., van Boven, A.J. et al. Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol 2003, 92(10): 1201-1203 (Pubitemid 37377833)
13. Berdowska, A. and Zwirska-Korczala, K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001, 26(5): 319-329
14. Vrecko, K., Staedtler, P., Mischak, I., Maresch, L. and Reibnegger, G. Periodontitis and concentrations of the cellular immune activation marker neopterin in saliva and urine. Clin Chim Acta 1997, 268(1-2): 31-40. (Pubitemid 28066800)
15. Millner, M.M., Franthal, W., Thalhammer, G.H. et al. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998, 44(1): 161-167 (Pubitemid 28042482)
16. Haavik, J. [From butterflies to neurobiology and the diagnosis of AIDS. The 100th anniversary of the discovery of pteridines]. Tidsskr Nor Laegeforen 1989, 109(19-21): 1986-1989
17. Muller, M.M., Curtius, H.C., Herold, M. and Huber, C.H. Neopterin in clinical practice. Clin Chim Acta 1991, 201(1-2): 1-16.
18. Oettl, K. and Reibnegger, G. Pteridines as inhibitors of xanthine oxidase: Structural requirements. Biochim Biophys Acta 1999, 1430(2): 387-395 (Pubitemid 29127234)
19. Reibnegger, C., Aichberger, C., Fuchs, D. et al. Posttransplant neopterin excretion in renal allograft recipients-a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival. Transplantation 1991, 52(1): 58-63.
20. Werner, E.R., Werner-Felmayer, G., Fuchs, D. et al. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-γ and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J Biol Chem 1990, 265(6): 3189-3192 (Pubitemid 20087300)
21. Huber, C., Batchelor, J.R., Fuchs, D. et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984, 160(1): 310-316 (Pubitemid 14089799)
22. Fuster, V., Badimon, L., Badimon, J.J. and Chesebro, J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992, 326(4): 242-50.
23. Fuster, V., Badimon, L., Badimon, J.J. and Chesebro, J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992, 326(5): 310-318
24. Moreno, P.R., Falk, E., Palacios, I.F., Newell, J.B., Fuster, V. and Fallon, J.T. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994, 90(2): 775-778
25. Libby, P. Molecular bases of the acute coronary syndromes. Circulation 1995, 91(11): 2844-2850
26. van der Wal, A.C., Becker, A.E., van der Loos, C.M. and Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89(1): 36-44.
27. Galis, Z.S., Sukhova, G.K., Lark, M.W. and Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94(6): 2493-2503 (Pubitemid 24379627)
28. Galis, Z.S. and Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90(3): 251-262
29. Schobersberger, W., Hoffmann, G., Grote, J., Wachter, H. and Fuchs, D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett 1995, 377(3): 461-464 (Pubitemid 26027163)
30. Werner-Felmayer, G., Werner, E.R., Fuchs, D. et al. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem 1993, 268(3): 1842-1846 (Pubitemid 23033583)
31. Hoffmann, G., Schobersberger, W., Frede, S. et al. Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. FEBS Lett 1996, 391(1-2): 181-184 (Pubitemid 26325739)
32. Barnes, P.J. and Karin, M. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336(15): 1066-1071 (Pubitemid 27163860)
33. Thurberg, B.L. and Collins, T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol 1998, 9(5): 387-396
34. Flugelman, M.Y., Virmani, R., Correa, R. et al. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation 1993, 88(6): 2493-2500
35. Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S. and Kaski, J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004, 110(13): 1747-1753 (Pubitemid 39299216)
36. Melichar, B., Gregor, J., Solichova, D., Lukes, J., Tichy, M. and Pidrman, V. Increased urinary neopterin in acute myocardial infarction. Clin Chem 1994, 40(2): 338-339
37. Schumacher, M., Halwachs, G., Tatzber, F. et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997, 30(3): 703-707 (Pubitemid 27397650)
38. Schumacher, M., Eber, B., Tatzber, F., Kaufmann, P., Esterbauer, H. and Klein, W. Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992, 94(1): 87-88
39. Gupta, S., Fredericks, S., Schwartzman, R.A., Holt, D.W. and Kaski, J.C. Serum neopterin in acute coronary syndromes. Lancet 1997, 349(9060): 1252-1253 (Pubitemid 27190062)
40. Avanzas, P., Arroyo-Espliguero, R., Cosin-Sales, J. et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 2004, (90): 847-852 (Pubitemid 39022574)
41. Garcia-Moll, X., Coccolo, F., Cole, D. and Kaski, J.C. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000, 35(4): 956-962 (Pubitemid 30189928)
42. Garcia-Moll, X., Cole, D., Zouridakis, E. and Kaski, J.C. Increased serum neopterin: A marker of coronary artery disease activity in women. Heart 2000, 83(3): 346-350 (Pubitemid 30313342)
43. Weiss, G., Willeit, J., Kiechl, S.F. et al. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994, 106(2): 263-271 (Pubitemid 24188768)
44. Gurfinkel, E.P., Scirica, B.M., Bozovich, G., Macchia, A., Manos, E. and Mautner, B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol 1999, 83(4): 515-518 (Pubitemid 29097948)
45. Erren, M., Reinecke, H., Junker, R. et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999, 19(10): 2355-2363 (Pubitemid 29477836)
46. Tanaka, T., Nakamura, Y., Nasuno, A. et al. Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Circ J 2004, 68(2): 114-120
47. Smith, S.C. Jr., Dove, J.T., Jacobs, A.K. et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001, 103(24): 3019-3041
48. Buffon, A., Biasucci, L.M., Liuzzo, G., D'Onofrio, G., Crea, F. and Maseri, A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002, 347(1): 5-12. (Pubitemid 34728951)
49. Rioufol, G., Finet, G., Ginon, I. E et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002, 106(7): 804-808
50. Asakura, M., Ueda, Y., Yamaguchi, O. et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study. J Am Coll Cardiol 2001, 37(5): 1284-1288
51. Bruschke, A.V., Wijers, T.S., Kolsters, W. and Landmann, J. The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients. Circulation 1981, 63(3): 527-536 (Pubitemid 11139860)
52. Kaski, J.C., Chester, M.R., Chen, L. and Katritsis, D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. Circulation 1995, 92(8): 2058-65.
53. Kaski, J.C., Chen, L. and Chester, M. Rapid angiographic progression of "target" and "nontarget" stenoses in patients awaiting coronary angioplasty. J Am Coll Cardiol 1995, 26(2): 416-421
54. Ridker, P.M., Buring, J.E., Shih, J., Matias, M. and Hennekens, C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98(8): 731-733 (Pubitemid 28391836)
55. Pasceri, V., Willerson, J.T. and Yeh, E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102(18): 2165-2168 (Pubitemid 30808000)
56. Yeh, E.T., Anderson, H.V., Pasceri, V. and Willerson, J.T. C-reactive protein: Linking inflammation to cardiovascular complications. Circulation 2001, 104(9): 974-975 (Pubitemid 32803869)
57. Auer, J., Berent, R., Lassnig, E., Weber, T. and Eber, B. Prognostic significance of immune activation after acute coronary syndromes. J Am Coll Cardiol 2002, 39(11): 1878. (Pubitemid 34595303)
58. Dominguez-Rodriguez, A., Abreu-Gonzalez, P. and Garcia-Gonzalez, M. Usefulness of neotperin levels and left ventricular function for risk assessment in survivors of acute myocardial infarction. Int J Cardiol 2006, 111: 318-320 (Pubitemid 44107575)